Senores Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the stock exchanges that its trading window will remain closed from July 1, 2025 until 48 hours after the announcement of its unaudited financial results for the quarter ending June 30, 2025. During this period, Directors, Promoters, Designated Persons, and their immediate relatives are prohibited from trading in the company's shares. This is a routine compliance step required under SEBI's insider trading rules before the company releases its quarterly results. The date of the board meeting to approve these results will be communicated separately.
This is a standard regulatory filing and does not impact the stock price directly. However, it signals that the company's Q1 FY26 earnings announcement is expected soon, which is when investors will get the next set of fundamental data points to react to.